The Board of Directors of I-Mab has authorized a buyback plan in August 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | -4.60% | -5.14% | -12.63% |
18/04 | Verastem Names John Hayslip as Chief Medical Officer | MT |
15/04 | I-Mab Announces Chief Medical Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.63% | 13Cr | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I-Mab authorizes a Buyback Plan.